Rosina Comas-Ghierra, Abdulkareem Alshaheeb, Melanie R McReynolds, Jennifer N Shepherd, Gustavo Salinas
{"title":"在寄生蠕虫中,Rhodoquinone保留了一种最小的Kynurenine途径,但对De Novo NAD+生物合成没有保留:NAD+救援途径的基本作用。","authors":"Rosina Comas-Ghierra, Abdulkareem Alshaheeb, Melanie R McReynolds, Jennifer N Shepherd, Gustavo Salinas","doi":"10.1089/ars.2023.0293","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Aims:</i></b> To determine the role of the kynurenine (KYN) pathway in rhodoquinone (RQ) and <i>de novo</i> NAD<sup>+</sup> biosynthesis and whether NAD<sup>+</sup> rescue pathways are essential in parasitic worms (helminths). <b><i>Results:</i></b> We demonstrate that RQ, the key electron transporter used by helminths under hypoxia, derives from the tryptophan (Trp) catabolism even in the presence of a minimal KYN pathway. We show that of the KYN pathway genes only the kynureninase and tryptophan/indoleamine dioxygenases are essential for RQ biosynthesis. Metabolic labeling with Trp revealed that the lack of the formamidase and kynurenine monooxygenase genes did not preclude RQ biosynthesis in the flatworm <i>Mesocestoides corti</i>. In contrast, a minimal KYN pathway prevented <i>de novo</i> NAD<sup>+</sup> biosynthesis, as revealed by metabolic labeling in <i>M. corti</i>, which also lacks the 3-hydroxyanthranilate 3,4-dioxygenase gene. Our results indicate that most helminths depend solely on NAD<sup>+</sup> rescue pathways, and some lineages rely exclusively on the nicotinamide salvage pathway. Importantly, the inhibition of the NAD<sup>+</sup> recycling enzyme nicotinamide phosphoribosyltransferase with FK866 led cultured <i>M. corti</i> to death. <b><i>Innovation:</i></b> We use comparative genomics of more than 100 hundred helminth genomes, metabolic labeling, HPLC-mass spectrometry targeted metabolomics, and enzyme inhibitors to define pathways that lead to RQ and NAD<sup>+</sup> biosynthesis in helminths. We identified the essential enzymes of these pathways in helminth lineages, revealing new potential pharmacological targets for helminthiasis. <b><i>Conclusion:</i></b> Our results demonstrate that a minimal KYN pathway was evolutionary maintained for RQ and not for <i>de novo</i> NAD<sup>+</sup> biosynthesis in helminths and shed light on the essentiality of NAD<sup>+</sup> rescue pathways in helminths.</p>","PeriodicalId":8011,"journal":{"name":"Antioxidants & redox signaling","volume":" ","pages":"737-750"},"PeriodicalIF":5.9000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Minimal Kynurenine Pathway Was Preserved for Rhodoquinone but Not for <i>De Novo</i> NAD<sup>+</sup> Biosynthesis in Parasitic Worms: The Essential Role of NAD<sup>+</sup> Rescue Pathways.\",\"authors\":\"Rosina Comas-Ghierra, Abdulkareem Alshaheeb, Melanie R McReynolds, Jennifer N Shepherd, Gustavo Salinas\",\"doi\":\"10.1089/ars.2023.0293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Aims:</i></b> To determine the role of the kynurenine (KYN) pathway in rhodoquinone (RQ) and <i>de novo</i> NAD<sup>+</sup> biosynthesis and whether NAD<sup>+</sup> rescue pathways are essential in parasitic worms (helminths). <b><i>Results:</i></b> We demonstrate that RQ, the key electron transporter used by helminths under hypoxia, derives from the tryptophan (Trp) catabolism even in the presence of a minimal KYN pathway. We show that of the KYN pathway genes only the kynureninase and tryptophan/indoleamine dioxygenases are essential for RQ biosynthesis. Metabolic labeling with Trp revealed that the lack of the formamidase and kynurenine monooxygenase genes did not preclude RQ biosynthesis in the flatworm <i>Mesocestoides corti</i>. In contrast, a minimal KYN pathway prevented <i>de novo</i> NAD<sup>+</sup> biosynthesis, as revealed by metabolic labeling in <i>M. corti</i>, which also lacks the 3-hydroxyanthranilate 3,4-dioxygenase gene. Our results indicate that most helminths depend solely on NAD<sup>+</sup> rescue pathways, and some lineages rely exclusively on the nicotinamide salvage pathway. Importantly, the inhibition of the NAD<sup>+</sup> recycling enzyme nicotinamide phosphoribosyltransferase with FK866 led cultured <i>M. corti</i> to death. <b><i>Innovation:</i></b> We use comparative genomics of more than 100 hundred helminth genomes, metabolic labeling, HPLC-mass spectrometry targeted metabolomics, and enzyme inhibitors to define pathways that lead to RQ and NAD<sup>+</sup> biosynthesis in helminths. We identified the essential enzymes of these pathways in helminth lineages, revealing new potential pharmacological targets for helminthiasis. <b><i>Conclusion:</i></b> Our results demonstrate that a minimal KYN pathway was evolutionary maintained for RQ and not for <i>de novo</i> NAD<sup>+</sup> biosynthesis in helminths and shed light on the essentiality of NAD<sup>+</sup> rescue pathways in helminths.</p>\",\"PeriodicalId\":8011,\"journal\":{\"name\":\"Antioxidants & redox signaling\",\"volume\":\" \",\"pages\":\"737-750\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antioxidants & redox signaling\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/ars.2023.0293\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antioxidants & redox signaling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/ars.2023.0293","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
A Minimal Kynurenine Pathway Was Preserved for Rhodoquinone but Not for De Novo NAD+ Biosynthesis in Parasitic Worms: The Essential Role of NAD+ Rescue Pathways.
Aims: To determine the role of the kynurenine (KYN) pathway in rhodoquinone (RQ) and de novo NAD+ biosynthesis and whether NAD+ rescue pathways are essential in parasitic worms (helminths). Results: We demonstrate that RQ, the key electron transporter used by helminths under hypoxia, derives from the tryptophan (Trp) catabolism even in the presence of a minimal KYN pathway. We show that of the KYN pathway genes only the kynureninase and tryptophan/indoleamine dioxygenases are essential for RQ biosynthesis. Metabolic labeling with Trp revealed that the lack of the formamidase and kynurenine monooxygenase genes did not preclude RQ biosynthesis in the flatworm Mesocestoides corti. In contrast, a minimal KYN pathway prevented de novo NAD+ biosynthesis, as revealed by metabolic labeling in M. corti, which also lacks the 3-hydroxyanthranilate 3,4-dioxygenase gene. Our results indicate that most helminths depend solely on NAD+ rescue pathways, and some lineages rely exclusively on the nicotinamide salvage pathway. Importantly, the inhibition of the NAD+ recycling enzyme nicotinamide phosphoribosyltransferase with FK866 led cultured M. corti to death. Innovation: We use comparative genomics of more than 100 hundred helminth genomes, metabolic labeling, HPLC-mass spectrometry targeted metabolomics, and enzyme inhibitors to define pathways that lead to RQ and NAD+ biosynthesis in helminths. We identified the essential enzymes of these pathways in helminth lineages, revealing new potential pharmacological targets for helminthiasis. Conclusion: Our results demonstrate that a minimal KYN pathway was evolutionary maintained for RQ and not for de novo NAD+ biosynthesis in helminths and shed light on the essentiality of NAD+ rescue pathways in helminths.
期刊介绍:
Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.
ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.
ARS coverage includes:
-ROS/RNS as messengers
-Gaseous signal transducers
-Hypoxia and tissue oxygenation
-microRNA
-Prokaryotic systems
-Lessons from plant biology